cancer « Science and Enterprise

AI-Designed Cancer Vaccine Shown to Act Against Melanoma

By Alan, on May 26th, 2023%

Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma

Crispr Therapy Shown to Remove E. Coli in Gut

By Alan, on May 5th, 2023%

New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics. . . . → Read More: Crispr Therapy Shown to Remove E. Coli in Gut

DNA Test Detects Early Bladder Cancer in Urine

By Alan, on May 2nd, 2023%

A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear. . . . → Read More: DNA Test Detects Early Bladder Cancer in Urine

Cancer Cell Therapy Biotech Launches, Raises $10M

By Alan, on April 11th, 2023%

A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds. . . . → Read More: Cancer Cell Therapy Biotech Launches, Raises $10M

T-Cell Biotech Gains €17.5M in Grant, Equity Funds

By Alan, on March 30th, 2023%

A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency. . . . → Read More: T-Cell Biotech Gains €17.5M in Grant, Equity Funds

HPV Vaccine Generates Immune Responses in Trial

By Alan, on March 20th, 2023%

Early results from a clinical trial show a vaccine for the human papillomavirus is safe and invokes immune responses in women with low-grade cervical lesions. . . . → Read More: HPV Vaccine Generates Immune Responses in Trial

Post-Surgical Fluid Cancer Analytics Company Gains $8M

By Alan, on March 16th, 2023%

A start-up company developing liquid biopsies for diagnosing cancer by analyzing fluids drained from a patient after surgery is raising $8 million in seed funds. . . . → Read More: Post-Surgical Fluid Cancer Analytics Company Gains $8M

A.I. Shown to Enhance Diagnostics in Liquid Biopsies

By Alan, on March 9th, 2023%

A new analysis shows machine learning algorithms can provide more diagnostic details in liquid biopsies, blood tests to detect and track solid tumor cancers. . . . → Read More: A.I. Shown to Enhance Diagnostics in Liquid Biopsies

Trial Testing VR to Relieve Cancer Patient Distress

By Alan, on March 7th, 2023%

A clinical trial is underway assessing virtual reality interventions for relieving distress and improve the quality of life for cancer patients receiving bone marrow transplants. . . . → Read More: Trial Testing VR to Relieve Cancer Patient Distress

Business-Academic Team to Create RNA Delivery for Cancer

By Alan, on March 2nd, 2023%

A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer

Subscribe for email alerts

Donate to Science & Enterprise

Like us on Facebook

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Specials

Guest Posts

Please share Science & Enterprise